share_log

Aura Biosciences | 8-K: Aura Biosciences Reports First Quarter 2023 Financial Results and Provides Clinical Development and Operational Highlights

SEC ·  May 12, 2023 04:20
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more